BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  New England Biolabs and CasZyme Collaborate to Enable Genome Editing Applications With Novel Cas9 Enzymes

  Under the terms of the agreement, CasZyme and NEB will apply their enzymology expertise to identify and characterize Cas nucleases.

  December 5, 2017

   · 

  3 min read
• Deals

  rfxcel Acquires Frequentz Assets

  Under this agreement, rfxcel acquires Frequentz technology, patents, contracts and personnel.

  December 5, 2017

   · 

  1 min read
• Business

  InstruSafe by Summit Medical Partners with the Senhance Surgical Robotic System to Launch Two New Surgical Instrument Trays

  The two new trays — an instrument tray and an endoscopic adapter tray — have both been validated specifically for the Senhance instrumentation.

  December 5, 2017

   · 

  1 min read
• Biotech Bay

  New Aurora Advanced Flow Cytometry System from Cytek Biosciences Resonates with Researchers Around the World

  In just a few short months, the Aurora advanced flow cytometry system from Cytek Biosciences Inc. has made a distinct impression on the scientific community.

  December 5, 2017

   · 

  2 min read
• Drug Development

  Updated Results From Calithera Biosciences’ Phase I Study of CB-839 in Combination With Paclitaxel in Patients With Triple Negative Breast Cancer to be Presented at the 2017 San Antonio Breast Cancer Symposium

  Based on these data, Calithera has opened a Phase 2 trial exploring the treatment combination in both first line and late line metastatic TNBC patients.

  December 5, 2017

   · 

  5 min read
• Biotech Bay

  Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy

  Bio-Rad today announces the launch of the QXDx BCR-ABL %IS Kit, the first CE-IVD digital PCR test that can monitor the molecular response of patients with CML to therapy, and it does so more precisely and reliably than other available technologies.

  December 5, 2017

   · 

  4 min read
• MorphoSys Announces That its Licensee Janssen Has Received Approval for Tremfya (Guselkumab) for the Treatment of Moderate-to-Severe Plaque Psoriasis in Canada

  Janssen’s Tremfya is now approved in the U.S., Canada and the European Union

  December 5, 2017

   · 

  3 min read
• AYOXXA Launches LUNARIS Human 11-Plex Ophthalmology Kit

  The assay is optimized for usage on LUNARIS, AYOXXA’s innovative multiplex protein analysis system.

  December 5, 2017

   · 

  7 min read
• Drug Development

  Poseida Therapeutics Presents Preclinical Solid Tumor Data for P-PSMA-101 at the American Association for Cancer Research Prostate Cancer Meeting

  The study was selected for oral presentation today at the American Association for Cancer Research Prostate Cancer: Advances in Basic, Translational, and Clinical Research meeting in Orlando, Florida.

  December 5, 2017

   · 

  5 min read
• Intellipharmaceutics Announces Receipt of Nasdaq Notice - Dec. 5, 2017

  The Notification Letter does not impact the Company’s listing on The Nasdaq Capital Market at this time.

  December 5, 2017

   · 

  11 min read